Use of colostrinin, constituent peptides thereof, and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S012200, C514S013800, C514S014800, C514S015800, C514S016700, C514S017400, C530S300000, C530S324000, C530S326000, C530S327000, C530S328000, C530S329000

Reexamination Certificate

active

06852685

ABSTRACT:
The present invention discloses a use of colostrinin, a constituent peptide thereof, and/or an analog thereof as a neural cell regulator in animals including humans.

REFERENCES:
patent: 4938949 (1990-07-01), Borch et al.
patent: 5595887 (1997-01-01), Coolidge et al.
patent: 6040180 (2000-03-01), Johe
patent: 6410058 (2002-06-01), Gohlke et al.
patent: 6500798 (2002-12-01), Stanton et al.
patent: 06 041191 (1994-02-01), None
patent: WO 9530686 (1995-11-01), None
patent: WO 9814473 (1998-04-01), None
patent: WO 9965329 (1999-12-01), None
patent: WO 0075173 (2000-12-01), None
patent: WO 0111937 (2001-02-01), None
patent: WO 0112650 (2001-02-01), None
patent: WO 0112651 (2001-02-01), None
Rao (1999) “Multipotent and Restricted Precursors in the Central Nervous System.” The Anatomical Record (NEW ANAT.) 257: 137-148.*
Schwab, M.E. Repairing the Injured Spinal Cord (2002) Science 295(8): 1029-1031.*
Inglot, A.D., Junsz, M., and Lisowski, J. Colostrinine:a Proline-Rich Polypeptide from Ovine Colostrum Is a Modest Cytokine Inducer in Human Leukocytes (1996) Archivum Immunologiae et Therapiae Experimentalis 44: 215-224.*
Ngo et al. Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox (1994) The Protein Folding Problem and Teriary Structure Prediction (#14), 491-495.*
Wells Addivity of Mutational Effects in Proteins (1990) Biochemistry (29): 37, 8509-8517.*
Kruzel et al. (Dec. 2001) “Towards and Understanding of Biological Role of Colostrinin Peptides.” Journal of Molecular Neuroscience 17(3): 379-389.*
Kandel et al. (2002) “Principles of Neural Science.” 4th Ed. pp. 67-81, 85-86.*
Bikfalvi et al. (Feb. 1997) “Biological Roles of Fibroblast Growth Factor-2” Endocrine Reviews 18(1): 26-45, especially Section F.*
Popik et al. (Jan. 29, 2001) “Cognitive effects of Colostral-Val nonapeptide in aged rats.” Behavioral Brain Research 118(2): 201-208.*
Janusz et al. (1987) mmunoregulatory Properties of Synthetic Peptides, Fragments of a Proline-Rich Polypeptide (PRP) from Ovine Colostrum. Molecular Immnuology 24(10): 1029-1031.*
Inglot, Junsz, and Lisowski Colostrinine:a Proline-Rich Polypeptide from Ovine Colostrum Is a Modest Cytokine Inducer in Human Leukocytes, 1996, Archivum Immunologiae et Therapiae Experimentalis (44) 215-224.*
Elgert, “Immunology: Understanding the Immune System” Text (1996) Wiley-Liss 1stEd. pp. 24-26 and 199-217.*
Altin et al., “Differential Induction of Primary-response (TIS) Genes in PC12 Pheochromocytoma Cells and the Unresponsive Variant PC12nnr5,”Journal of Biological Chemistry,Mar. 25, 1991; 266(9): 5401-5406.
Anneren et al., “GTK, a Src-related Tyrosine Kinase, Induces Nerve Growth Factor-independent Neurite Outgrowth in PC 12 Cells through Activation of the Rap1 Pathway,”Journal of Biological Chemistry,Sep. 15, 2000;275(37): 29153-29161.
Bagchi et al., “Comparative in vitro and in vivo protein kinase C activation by selected pesticides and transition metal salts,”Toxicology Letters,1997;91: 31-37.
Chen et al., “Lithium Increase Tyrosine Hydroxylase Levels both In Vivo and In Vitro,”Journal of Neurochemistry,1998;70(4): 1768-1771.
Cui et al., “Effect of Nucleoside Analogs on Neurite Regeneration and Mitochondrial DNA Synthesis in PC-12 Cells,”Journal of Pharmacology and Experimental Therapeutics,1997;280(3): 1228-1234.
Dagø et al., “NS 1231, a novel compound with neurotrophic-like effects in vitro and in vivo,”Journal of Neurochemistry,2002;81: 17-24.
DeJongh et al., “Estimation of Systemic Toxicity of Acrylamide by Integration of in vitro Toxicity Data with Kinetic Simulations,”Toxicology and Applied Pharmacology,1999;158: 261-268.
Doye et al., “Phosphorylation of Stathmin and Other Proteins Related to Nerve Growth Factor-induced Regulation of PC12 Cells,”Journal of Biological Chemistry,Jul. 15, 1990;265(20): 11650-11655.
Feng et al., “NF-κB/Rel Proteins are Required for Neuronal Differentiation of SH-SY5Y Neuroblastoma Cells,”Journal of Biological Chemistry,Oct. 22, 1999;274(43): 30341-30344.
Kim et al., “Insulin-like Growth Factor-I-mediated Neurite Outgrowth in Vitro Requires Mitogen-activated Protein Kinase Activation,”Journal of Biological Chemistry,Aug. 22, 1997;272(34): 21268-21273.
Kim et al., “Differential Regulation of Insulin Receptor Substrate-2 and Mitogen-Activated Protein Kinase Tyrosine Phosphorylation by Phosphatidylinositol 3-Kinase Inhibitors in SH-SY5Y Human Neuroblastoma Cells,”Endocrinology,1998;139(12): 4881-4889.
Lachyankar et al., “A Role for Nuclear PTEN in Neuronal Differentiation,”Journal of Neuroscience,Feb. 15, 2000;20(4): 1404-1413.
Noble et al., “Overexpression of Dynamin is Induced by Chronic Stimulation of μ- but Not δ-Opioid Receptors: Relationships with μ-Related Morphine Dependence,”Molecular Pharmacology,2000;58: 159-166.
Ponthan et al., “The Synthetic Retinoid RO 13-6307 induces Neuroblastoma Differentiation in vitro and inhibits Neuroblastoma Tumour growth in vivo,”Int. J. Cancer,2003;104: 418-424.
Puglianiello et al., “IGF-I stimulates chemotasix of human neuroblasts. Involvement of type 1 IGF receptor, IGF binding proteins, phosphatidylinositol-3 kinase pathway and plasmin system,”Journal of Endocrinology,2000;165: 123-131.
Xiang-Ming et al., “Gating kinetics of potassium channel and effects of nerve growth factors in PC12 cells analyzed with fractal model,”Acta Pharmacol Sin,Feb. 2001;22(2): 103-110.
Zhen et al., “Lithium regulates protein tyrosine phosphatase activity in vitro and in vivo,”Psychopharmacology,2002;162: 379-384.
Cosgaya et al., “Neuronal differentiation of PC12 cells induced by engrailed homeodomain is DNA-binding specific and independent of MAP kinases,”Journal of Cell Science1998; 111: 2377-2384.
Elgert, “Immunology: Understanding the Immune System,” Text (1996) Wiley-Liss 1stEd. pp. 24-26 and 199-217.
Kimball, John W., “White Blood Cells (leukocytes),”Kimball's Biology Papers[online]. [retrieved on Dec. 2, 2000]. 2 pgs.
Leszek et al., “Colostrinin® proline-rich polypeptide compley from ovine colostrum- a long-term study of its efficacy in Alzheimer's disease,”Med Sci Monit.,2002;8(10): 193-196.
Vaudry et al., “Signaling Pathways for PC12 Cell Differentiation: Making the Right Connections,”ScienceMay 31, 2002;296: 1648-1649.
Babbit, ed.,The Vanderbilt Rubber Handbook,R.T. Vanderbilt Company, Inc., Norwalk, CT, pp. 344-397 (1978).
Bespalov et al., “Fabs specific for 8-oxoguanine: control of DNA binding,”J Mol Biol.Nov. 12, 1999; 293(5):1085-95.
Blach-Olszewska et al., “Stimulatory effect of ovine colostrinine (a proline-rich polypeptide) on interferons and tumor necrosis factor production by murine resident peritoneal cells,”Arch Immunol Ther Exp(Warsz), 1997;45(1):43-7.
Buescher et al., “Colostral antioxidants: separation and characterization of two activities in human colostrum,”J Pediatr Gastroenterol Nutrl.Jan. 1992; 14(1):47-56.
Calingasan et al., “Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease,”J Neurochem.Feb. 1999;72(2):751-6.
Chao “Growth factor signaling: where is the specificity?”Cell. Mar. 20, 1992;68(6):995-7.
Esterbauer et al., “Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes,”Free Radic Biol Med. 1991;11(1):81-128.
Fields et al.,Synthetic Peptides: A User's Guide,W.M. Freeman & Company, New York, NY, pp. 77-183 (1992).
Fillmore et al., “Differentiation of PC12 cells with nerve growth factor is associated with induction of transin synthesis and release,”J Neurosci Res.Apr. 1992;31(4):662-9.
Gabbita et al., “Increased nuclear DNA oxidation in the brain in Alzheime

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of colostrinin, constituent peptides thereof, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of colostrinin, constituent peptides thereof, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of colostrinin, constituent peptides thereof, and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3505151

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.